Richmond, Virginia, May 15, 2025 (GLOBE NEWSWIRE) -- New findings from a retrospective analysis of U.S. commercial claims data indicate that patients prescribed AUVI-Q ® (epinephrine injection, USP) ...

Glen Allen, VA, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Kaléo, a global leader in drug-device combinations and auto-injector innovation, recognizes its 25th anniversary by celebrating the people, purpose, ...

Read full article: Winter Weather Advisory issued for Metro Detroit Read full article: Teenager charged with making terroristic threats toward Ann Arbor elementary school Police are seeking ...

Richmond, Virginia, July 24, 2025 (GLOBE NEWSWIRE) -- Kaléo, a global leader in drug-delivery device technology and auto-injector innovation, today announced that AUVI-Q® (epinephrine injection, USP) ...

Auvi-Q (epinephrine) is a brand-name injectable drug. It’s prescribed for emergency treatment of severe allergic reactions. Auvi-Q has interactions with some other drugs, including diuretics and ...

Auvi-Q epinephrine injectors, which are used to save the lives of people suffering serious allergic reactions, are being recalled because they could deliver the wrong dosages.

BRIDGEWATER, N.J.-- Sanofi is recalling hundreds of thousands of epinephrine injectors used to treat severe allergic reactions because they may not deliver the correct amount of the life-saving drug.

The EpiPen, the anti-allergy device that has been under investigation because of huge price increases, is soon going to have some competition. Kaleo Pharmaceuticals, a small privately held drugmaker, ...

Thousands of Auvi-Q epinephrine autoinjectors, the blockbuster invention of two Richmond-area brothers, are being recalled by Sanofi US because the devices might not deliver an adequate dose of ...